We are live on ! Find out more
NEO icon

NeoGenomics

Positive
Neutral
Negative
Sentiment 3-Months
Positive 7.1%
Neutral 92.9%
Negative 0%

Neutral
Business Wire
7 days ago
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with prostate adenocarcinoma.
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
Neutral
Business Wire
9 days ago
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will report its second quarter 2026 financial results after the close of U.S. financial markets on Tuesday, July 28, 2026.
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
Neutral
Business Wire
21 days ago
NeoGenomics Appoints Carolyn Starrett to its Board of Directors
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the appointment of Carolyn Starrett to its Board of Directors.
NeoGenomics Appoints Carolyn Starrett to its Board of Directors
Positive
Zacks Investment Research
27 days ago
NeoGenomics (NEO) Soars 7.2%: Is Further Upside Left in the Stock?
NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NeoGenomics (NEO) Soars 7.2%: Is Further Upside Left in the Stock?
Neutral
Business Wire
29 days ago
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes.
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
Neutral
Business Wire
1 month ago
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes.
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
Neutral
Business Wire
1 month ago
NeoGenomics to Present New Research at ASCO Annual Meeting 2026
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will showcase nine scientific abstracts at the 2026 ASCO Annual Meeting, May 29–June 2, 2026, in Chicago (booth #32130).
NeoGenomics to Present New Research at ASCO Annual Meeting 2026
Neutral
GlobeNewsWire
1 month ago
Neo Performance Materials Announces C$100 Million Bought Deal Treasury Offering of Common Shares
The base shelf prospectus is accessible, and the prospectus supplement will be accessible within two business days through SEDAR+ The base shelf prospectus is accessible, and the prospectus supplement will be accessible within two business days through SEDAR+
Neo Performance Materials Announces C$100 Million Bought Deal Treasury Offering of Common Shares
Neutral
GlobeNewsWire
1 month ago
Neo Partners with Greenland Mines to Advance Sarfartoq Rare Earth Project
Strategic partnership positions Greenland Mines to lead exploration while Neo retains equity stake and offtake rights Strategic partnership positions Greenland Mines to lead exploration while Neo retains equity stake and offtake rights
Neo Partners with Greenland Mines to Advance Sarfartoq Rare Earth Project
Neutral
Business Wire
2 months ago
NeoGenomics to Participate in Upcoming Investor Conferences
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences: The 23rd Annual Craig-Hallum Institutional Investor Conference in Minneapolis Investor 1x1 meetings on Thursday, May 28th The Jefferies Global Healthcare Conference 2026 in New York Fireside chat on Thursday, June 4th, at 10:30am EDT, and investor 1x1 meetings A w.
NeoGenomics to Participate in Upcoming Investor Conferences